Correction to "Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study" [The Lancet Regional Health - Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366

Lancet Reg Health Am. 2023 Feb:18:100422. doi: 10.1016/j.lana.2022.100422. Epub 2022 Dec 29.

Authors

Pedro I Más-Bermejo¹, Félix O Dickinson-Meneses¹, Kenia Almenares-Rodríguez², Lizet Sánchez-Valdés³, Raúl Guinovart-Díaz⁴, María Vidal-Ledo², Enrique Galbán-García⁵, Yadira Olivera-Nodarse⁶, Isabel Morgado-Vega⁶, Santiago Dueñas-Carrera⁷, Merardo Pujol⁷, Francisco Hernández-Bernal⁷, Miladys Limonta-Fernández⁷, Gerardo Guillén-Nieto⁷, Verena L Muzio-González⁷, Marta Ayala-Ávila⁷

Affiliations

¹ Pedro Kourí Tropical Medicine Institute, Havana, Cuba.
² National School of Public Health, Havana, Cuba.
³ Molecular Immunology Centre, Havana, Cuba.
⁴ Mathematics and Computing Department, University of Havana, Havana, Cuba.
⁵ National Institute of Gastroenterology, Havana, Cuba.
⁶ Provincial Hygiene, Epidemiology and Microbiology Centre, Havana, Cuba.
⁷ Genetic Engineering and Biotechnology Centre, Havana, Cuba.

Abstract

[This corrects the article DOI: 10.1016/j.lana.2022.100366.].

© 2022 The Author(s).

Publication types

Published Erratum